I sat down with #CAI's VP Marketing and Consulting Services, David Shenberger and Chief Strategy Officer Alice Redmond to look back at 2022, and get some predictions for 2023

We discussed #consolidationofassets and pipelines, #ATMPS, #RegulatoryFrameworks, #AI #Pharma4.0, #ChatGPT, #pharmapricing, #outsourcing and a lot more.

I asked....

2022 𝐑𝐞𝐟𝐥𝐞𝐜𝐭𝐢𝐨𝐧𝐬
• Can you give me a quick overview of CAI? 00:43
• One word to describe 2022 and why? 01:49
• What were some of CAI key achievements in 2022? 03:00
• Have clients expectations changed since the pandemic? 04:19
• Looking back at 2022 what challenges did you see the sector face, and developments stood out for you? 06:00
• Does the growth of ATMPS changed how they work with clients? 09:07
• Are there any areas you think the industry could improve? 10:36

2023 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭𝐬
• What are your predictions for the #LifeSciences, #Pharma and #BioPharma in 2023? 12:06
• What developments and trends do you expect to see/predict for #PharmaManufacturing? 16:55
• What can we expect CAI in 2023? 17:44
• Finally, what last thoughts would you like to leave viewers with for 2023? 20:45

🎞 WATCH the interview here https://lnkd.in/eMWuGXmF

Feel free to leave any questions or comments for Alice or David below.

You can learn more about CAI at www.cagents.com